Catalent: Novo Holdings' Strategic Acquisition in Pharma
Deal News | Jan 30, 2025 | Legal Community Swiss
Walder Wyss, a Swiss law firm, has successfully advised Novo Holdings, a Danish life sciences investor, in its acquisition of specific operations from Catalent, an American pharmaceutical multinational. The acquisition will see Novo Holdings integrate three of Catalent's production units into the Novo Nordisk Foundation, which serves as the parent company. Catalent is known for its specialisation in gene therapies and clinical supply solutions and serves a global clientele. The Walder Wyss team was led by partner Luc Defferrard and counsel Iliana Djagova, and included expertise from various legal areas such as employment law, tax, IP/IT, and real estate to support the transaction.
Sectors
- Pharmaceuticals
- Life Sciences
- Legal Advisory
Geography
- Denmark – Novo Holdings is based in Denmark, making it a key geographical area for the article.
- United States – Catalent is an American pharmaceutical multinational, which is central to the acquisition.
- Switzerland – Walder Wyss, the legal firm advising on the acquisition, is based in Switzerland.
Industry
- Pharmaceuticals – The article involves Catalent, a major player in the pharmaceutical industry, specializing in gene therapies and clinical supply solutions.
- Life Sciences – Novo Holdings' expansion reflects its strong involvement in life sciences, which aligns with its strategic acquisition from Catalent.
- Legal Advisory – Walder Wyss played a critical role as legal advisors in the M&A transaction, highlighting their expertise in corporate and M&A law.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Novo Holdings | Bidding Company | Company | A Danish life science investor acquiring parts of Catalent's operations. |
| Catalent | Target Company | Company | An American pharmaceutical multinational specialising in gene therapies and clinical supply solutions. |
| Walder Wyss | Legal Advisor | Company | A Swiss law firm advising Novo Holdings on the Swiss aspects of the transaction. |
| Luc Defferrard | Co-lead Partner | Person | Partner at Walder Wyss leading the corporate/M&A aspect of the transaction. |
| Iliana Djagova | Co-lead Counsel | Person | Counsel at Walder Wyss co-leading the corporate/M&A aspect of the transaction. |